文献速递慢性肾脏病肾血管病与高血压

心血管疾病生物标志物与suPAR在预测肾功能下降中的作用:一项前瞻性队列研究

Cardiovascular Disease Biomarkers and suPAR in Predicting Decline in Renal Function: A Prospective Cohort Study.
PubMed 文献 · Kidney Int Rep · 2017-02-09

在Emory心血管生物库3282名成人中,评估hs-CRP、FDP、HSP-70、hs-TnI与suPAR对eGFR下降的预测价值。中位随访3.5年,仅suPAR独立预测eGFR下降,其他心血管生物标志物均无显著关联。

要点

  • hs-CRP、FDP、HSP-70、hs-TnI与eGFR下降无显著关联
  • suPAR在校正所有生物标志物后仍预测eGFR下降
  • suPAR与肾病的关联可能反映肾脏病特异性通路

核心结论

  • hs-CRP、FDP、HSP-70和hs-TnI与eGFR下降无关,而suPAR独立预测eGFR下降。

研究设计与样本

  • 前瞻性队列研究,纳入Emory心血管生物库3282名成人,平均年龄63岁,64%男性,75% eGFR>60 ml/min/1.73 m2。
  • 基线测量suPAR、hs-CRP、HSP-70、FDP和hs-TnI血浆水平,随访2672人(中位3.5年)评估eGFR变化。

主要发现

  • 生物标志物间相关性弱(r范围0.17-0.28)。
  • hs-CRP、FDP、hs-TnI和suPAR独立与基线eGFR和蛋白尿相关。
  • eGFR年下降中位数为-0.6 ml/min/1.73 m2。
  • hs-CRP(β: -0.04; P = 0.46)、FDP(β: -0.13; P = 0.08)、HSP-70(β: 0.05; P = 0.84)、hs-TnI(β: -0.01; P = 0.76)与eGFR下降无显著关联。
  • suPAR在校正所有生物标志物后仍预测eGFR下降。

关键数值与推荐

  • eGFR年下降中位数为-0.6 ml/min/1.73 m2。
  • hs-CRP与eGFR下降的β为-0.04(P = 0.46),FDP为-0.13(P = 0.08),HSP-70为0.05(P = 0.84),hs-TnI为-0.01(P = 0.76)。

临床怎么用

  • 在心血管疾病患者中,suPAR可用于识别肾功能下降高风险个体。
  • hs-CRP、FDP、HSP-70和hs-TnI不推荐用于预测肾功能下降。

局限性

  • 尿液蛋白仅1335名受试者有基线数据。
  • 随访eGFR数据仅2672名受试者可用。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

INTRODUCTION: Soluble urokinase-type plasminogen activator receptor (suPAR) strongly predicts outcomes and incident chronic kidney disease (CKD) in patients with cardiovascular disease (CVD). Whether the association between suPAR and CKD is a reflection of its overall association with chronic inflammation and poor CVD outcomes is unclear. We examined whether CVD biomarkers, including high-sensitivity C-reactive protein (hs-CRP), fibrin-degradation products (FDPs), heat-shock protein 70 (HSP-70), and high-sensitivity troponin I (hs-TnI) were associated with a decline in kidney function in the Emory Cardiovascular Biobank cohort, in which suPAR levels were shown to be predictive of both incident CKD and CVD outcomes. METHODS: We measured suPAR, hs-CRP, HSP-70, FDP, and hs-TnI plasma levels in 3282 adults (mean age 63 years, 64% male, 75% estimated glomerular filtration rate [eGFR] >60 ml/min per 1.73 m2). Glomerular filtration rate was estimated using Chronic Kidney Disease-Epidemiology Collaboration (eGFR) at enrollment (n = 3282) and follow-up (n = 2672; median 3.5 years). Urine protein by dipstick at baseline was available for 1335 subjects. RESULTS: There was a weak correlation among biomarkers (r range: 0.17-0.28). hs-CRP, FDPs, hs-TnI, and suPAR were independently associated with baseline eGFR and proteinuria. The median yearly decline in eGFR was -0.6 ml/min per 1.73 m2. hs-CRP (β: -0.04; P = 0.46), FDPs (β: -0.13; P = 0.08), HSP-70 (β: 0.05; P = 0.84), or hs-TnI (β: -0.01; P = 0.76) were associated with eGFR decline. suPAR remained predictive of eGFR decline even after adjusting for all biomarkers. DISCUSSION: hs-CRP, FDP, HSP-70, and hs-TnI were not associated with eGFR decline. The specific association of suPAR with eGFR decline supported its involvement in pathways specific to the pathogenesis of kidney disease.

来源:Kidney Int Rep,查看原文。版权归原作者所有。

引用

  1. Hayek SS, Ko YA, Awad M, et al. Cardiovascular Disease Biomarkers and suPAR in Predicting Decline in Renal Function: A Prospective Cohort Study. Kidney Int Rep. 2017. PMID: 29142970. doi:10.1016/j.ekir.2017.02.001

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。